Indivior Pharmaceuticals (INDV) Receivables Refunds (2021 - 2025)
Historic Receivables Refunds for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $13.0 million.
- Indivior Pharmaceuticals' Receivables Refunds fell 3500.0% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year decrease of 3500.0%. This contributed to the annual value of $33.0 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Receivables Refunds is $13.0 million, which was down 3500.0% from $3.0 million recorded in Q2 2025.
- Indivior Pharmaceuticals' Receivables Refunds' 5-year high stood at $33.0 million during Q4 2024, with a 5-year trough of $3.0 million in Q2 2025.
- Moreover, its 5-year median value for Receivables Refunds was $13.0 million (2021), whereas its average is $15.8 million.
- The largest annual percentage gain for Indivior Pharmaceuticals' Receivables Refunds in the last 5 years was 22222.22% (2025), contrasted with its biggest fall of 8636.36% (2025).
- Quarter analysis of 5 years shows Indivior Pharmaceuticals' Receivables Refunds stood at $13.0 million in 2021, then plummeted by 61.54% to $5.0 million in 2022, then soared by 220.0% to $16.0 million in 2023, then skyrocketed by 106.25% to $33.0 million in 2024, then crashed by 60.61% to $13.0 million in 2025.
- Its last three reported values are $13.0 million in Q3 2025, $3.0 million for Q2 2025, and $29.0 million during Q1 2025.